Margaret (Meg) Gamalo-Siebers is a Filipino-American biostatistician and drug development executive specializing in inflammation and immunology. She works for Pfizer as vice president – biostatistics, global product development – inflammation and immunology, and is editor-in-chief of the Journal of Biopharmaceutical Statistics.[1][2]

Education and career

Gamalo earned a master's degree in applied mathematics and operations research from the University of the Philippines. She completed a Ph.D. in statistics at the University of Pittsburgh,[3] in 2006.[4]

She worked in the Center for Drug Evaluation and Research at the US Food and Drug Administration, and as a principal research scientist and research advisor for global statistical sciences at Eli Lilly, before taking her present position at Pfizer.[1][3][4]

Recognition

Gamalo was named as a Fellow of the American Statistical Association, in the 2023 class of fellows.[5]

References

  1. 1 2 Seifu, Yodit; Chang, Victoria; Lin, Junjing (December 1, 2020), "An Interview with Margaret Gamalo, Editor of JBS", Amstat News, American Statistical Association, retrieved 2023-10-16
  2. ↑ "Editorial board", Journal of Biopharmaceutical Statistics web site, Taylor & Francis, retrieved 2023-10-16
  3. 1 2 Schacht, Alexander, "How to combine a control arm with RWE data: Interview with Margaret Gamalo", The Effective Statistician, retrieved 2023-10-16
  4. 1 2 Past graduates, University of Pittsburgh Department of Statistics, retrieved 2023-10-16
  5. ↑ 2023 ASA Fellows (PDF), American Statistical Association, retrieved 2023-10-16
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.